PSS14 COST-UTILITY ANALYSIS OF RANIBIZUMAB (LUCENTIS®) IN WET-AMD BASED ON REAL-LIFE DATA COLLECTED IN THE HELIOS STUDY AFTER RANIBIZUMAB REIMBURSEMENT IN BELGIUM

✍ Scribed by K. Moeremans; L. Gerlier; S. Drieskens; L. Annemans; H. Brié; M. Deruyck; P. Faes; S. Vancayzeele

• Book ID: 119309100
• Publisher: John Wiley and Sons
• Year: 2011
• Tongue: English
• Weight: 60 KB
• Volume: 14
• Category: Article
• ISSN: 1098-3015
• DOI: 10.1016/j.jval.2011.02.316